Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice

Journal of Infectious Diseases

Volumn 180, Issue 1, 1999, Pages 238-241

  Moazed, Teresa C ^a,c   Campbell, Lee Ann ^a   Rosenfeld, Michael E ^a,b   Grayston, J Thomas ^a   Kuo, Cho chou ^a,b  

^a Department of Pathobiology ^*  (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ARCH; ARTICLE; ATHEROSCLEROSIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; HEART WEIGHT; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; AORTA, THORACIC; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS;

EID: 0033051627     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314855     Document Type: Article

References (14)

1. Grayston JT, Kuo CC, Campbell LA, Wang SP, Jackson LA. Chlamydia pneumoniac and cardiovascular disease. Cardiologia 1997;42:1145-51.
2. Saikku P, Mattila K, Nieminen MS, et al. Serological evidence an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;2:983-6.
3. Kuo CC, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993;167:841-9.
4. Ramirez JA, the Chlamydia pneumoniae/atherosclerosis study group. Isolation of Chlamydia pneumoniae (TWAR) in coronary arteries of a patient with coronary atheroselerosis. Ann Intern Med 1996;125:979-82.
5. Jackson LA, Campbell LA, Kuo CC, Rodriguez DL, Lee A, Grayston JT. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis 1997;176:292-5.
6. Piedrahita JA, Zhang SH, Hagaman JR, Oliver PM, Maeda N. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic from stem cells. Proc Natl Acad Sci USA 1992;89:4471-5.
7. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 1994;14:133-40.
8. Moazed TC, Kuo CC, Grayston JT, Campbell LA. Murine models of Chlamydia pneumoniae infection and atherosclerosis. J Infect Dis 1997;175:883-90.
9. Seo HS, Lombardi DM, Polinsky P, et al. Peripheral vasculature stenosis in apolipoprotein-E deficient mice: Potential roles of medial atrophy and adventitial inflammation. Arterioscler Thromb Vasc Biol 1997;17:3593-601.
10. Fong IW, Chiu B, Viira E, Fong MW, Jang D, Mahony J. Rabbit model for Chlamydia pneumoniaeinfection. J Clin Microbiol 1997;35:48-52.
11. Laitinen K, Laurila A, Pyhala L, Leinonen M, Saikku P. Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits. Infect Immun 1997;65:4832-5.
12. Mühlestein JB, Anderson JL, Hammond EH, et al. Infection with Chlamydia pneumoniae accelerates the development of the atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 1998;97:633-6.
13. Meraihi Z, Lutz O, Scheftel JM, Frey A, Ferezou J, Bach AC. Decreased lipolytic activity in tissues during infectious and inflammatory stress. Nutrition 1991;7:93-8.
14. Moazed TC, Kuo CC, Grayston JT, Campbell LA. Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J Infect Dis 1998;177:1322-5.